New publication: Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Jason P. Gleghorn , Erica D. Pratt , Denise Denning , He Liu , Neil H. Bander , Scott T. Tagawa , David M. Nanus , Paraskevi A. Giannakakou and Brian J. Kirby
Lab Chip, 2010,10, 27-29, DOI: 10.1039/B917959C
Abstract
Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.
